Dabur`s anti-cancer drug for Abbott
After a year of hectic negotiations, Dabur Pharmaceuticals has struck an exclusive strategic alliance with the $18-billion Abbott Laboratories Inc of the US. According to the agreement, Abbott will
After a year of hectic negotiations, Dabur Pharmaceuticals has struck an exclusive strategic alliance with the $18-billion Abbott Laboratories Inc of the US. According to the agreement, Abbott will